Research Article
Prospective, Multi-centric, In-clinic, Observational Study on ChilRun FullTM: An Oral Nutritional Supplement for Growth and Development
Jain Naveen K*, Kumar Dheeraj, Khan Amera, and Patil Chandrashekhar S
Department of Biology Research/New Products, Panacea Biotec Ltd., B-1 Extn./A-27 Mohan Co-operative industrial Estate, Mathura Road, New Delhi, India
*Corresponding author:Naveen K Jain, Department of Biology Research/New Products, Panacea Biotec Ltd., B-1 Extn./A-27 Mohan Co-operative industrial Estate, Mathura Road, New Delhi, India Email: naveenjain@panaceabiotec.com
Article Information: Submission: 17/10/2024; Accepted: 05/11/2024; Published: 09/11/2024
Copyright: © 2024 Jain Naveen K, et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Nutritional supplements have increasingly been recognised as one of the most effective and appropriate strategies for enhancing growth and overall physical health of children. Post-marketing, multi-centric in-clinic observational study, was undertaken to evaluate the effect of ChilRun FullTM, an oral nutritional supplement, on the growth and developmental parameters of children aged two years and above. ChilRun FullTM is a 37 nutrient based oral supplement for children 2+ age groups which has balanced macro and micronutrients. In this study, ChilRun FullTM was administered twice a day (serving size either with milk or water) along with routine eating habits under the recommendations of paediatricians) to a total of 665 kids (≥2 years) from the Eastern part of India for a
period of three months. During the study period anthropometric measurements including height, weight and body mass index (BMI) were measured at baseline (day 0), on days 30, 60 and 90 of the study period, and data was recorded in Case report Form (CRF).
The assessment of the outcomes was conducted utilizing Z-scores for height, weight and BMI, which served as critical metrics for determining the significance of the findings of growth and development. The results indicate significant improvements in height, weight and BMI across all age categories. In 2-3 years, 4-6 years and 7-9 years age group, the average height increased from 95.96 cm at baseline to 97.57 cm, 110.31 to 111.75 cm and 123.91 to 125.26 cm, respectively by day 90, while the weight increased from 15.09 kg to 16.25 kg, 21.50 to 22.54 kg and 25.56 to 26.31 kg. Similarly, the BMI showed a consistent upward trend, indicating healthy weight gain in proportion to height.
The findings suggest that the ChilRun FullTM nutritional supplement plays a crucial role in supporting the growth and development of growing children and contributing to a significant increase in both height, weight and BMI across the various age groups of children.
The assessment of the outcomes was conducted utilizing Z-scores for height, weight and BMI, which served as critical metrics for determining the significance of the findings of growth and development. The results indicate significant improvements in height, weight and BMI across all age categories. In 2-3 years, 4-6 years and 7-9 years age group, the average height increased from 95.96 cm at baseline to 97.57 cm, 110.31 to 111.75 cm and 123.91 to 125.26 cm, respectively by day 90, while the weight increased from 15.09 kg to 16.25 kg, 21.50 to 22.54 kg and 25.56 to 26.31 kg. Similarly, the BMI showed a consistent upward trend, indicating healthy weight gain in proportion to height.
The findings suggest that the ChilRun FullTM nutritional supplement plays a crucial role in supporting the growth and development of growing children and contributing to a significant increase in both height, weight and BMI across the various age groups of children.
Keywords:Oral Nutrition supplement; ChilRun FullTM; Growth chart; BMI; Z-score